Axsome Therapeutics, Inc. (AXSM)
173.12
+4.38
(+2.60%)
USD |
NASDAQ |
Apr 08, 16:00
173.12
0.00 (0.00%)
After-Hours: 16:05
Axsome Therapeutics Cash from Investing (TTM) : -0.48M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | -302.56M |
| Madrigal Pharmaceuticals, Inc. | 32.32M |
| Amicus Therapeutics, Inc. | -46.43M |
| Insmed, Inc. | -64.58M |
| MannKind Corp. | -304.80M |